Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4684113

COC(=O)c1ccc(NC(=N)N)cc1OC.O=C(O)C(F)(F)F

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
TDP1 Q9NUW8 1/20 0.45
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
MAPT P10636 2/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
LMNA P02545 2/20 0.44
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 2/20 0.44
HPGD P15428 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
KLK1 P06870 2/20 0.42
KLK5 Q9Y337 2/20 0.42
F2 P00734 1/20 0.42
IMPDH2 P12268 1/20 0.41
IMPDH1 P20839 1/20 0.41
CFTR P13569 1/20 0.40
MCHR1 Q99705 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12198690 0.91 TDP1 (0.52) CYP1A2CYP2C9CYP2C19TDP1KMT2A
Hydrochloric Acid SCHEMBL16701818 0.90 TDP1 (0.51) CYP1A2CYP2C9CYP2C19TDP1KMT2A
Nitric Acid SCHEMBL2511257 0.84 HTT (0.47) CYP1A2CYP2C9CYP2C19TDP1KMT2A
SCHEMBL2390452 0.83 ALDH1A1 (0.55) CYP1A2CYP2C9CYP2C19TDP1KMT2A
Hydrochloric Acid SCHEMBL2512014 0.81 ALDH1A1 (0.54) CYP1A2CYP2C9CYP2C19TDP1KMT2A
SCHEMBL7965219 0.77 F2 (0.52) TDP1KMT2AMEN1MAPTSMN1; SMN2
SCHEMBL2555975 0.75 TDP1 (0.73) CYP1A2CYP2C9CYP2C19TDP1KMT2A
Trifluoroacetic Acid SCHEMBL6171741 0.74 IMPDH2 (0.64) IMPDH2IMPDH1
SCHEMBL1184403 0.74 KMT2A (0.57) CYP1A2CYP2C9CYP2C19KMT2AMEN1
SCHEMBL9430586 0.74 KDM4E (0.55) CYP1A2CYP2C9CYP2C19TDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1236712-B1 AMIDINOPHENYLPYRUVIC ACID DERIVATIVE AJINOMOTO KK (JP) 2008-08-06 EP disclosed
US-6710056-B2 PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVE AN EXCELLENT ANTAGONISTIC EFFECT AGAINST ACTIVATED BLOOD COAGULATION FACTOR VII. AJINOMOTO CO., INC. (JP) 2004-03-23 US disclosed
US-20030109547-A1 Amidinophenylpyruvic acid derivatives AJINOMOTO CO. INC (JP) 2003-06-12 US disclosed
EP-1236712-A1 AMIDINOPHENYLPYRUVIC ACID DERIVATIVE Ajinomoto Co., Inc. (JP) 2002-09-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030109547-A1 Amidinophenylpyruvic acid derivatives HABP2, F2, F7 CYP1A2 724/4885CYP2C9 184/4885CYP2C19 183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.